The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
quan gu tong shou ti zu duan ji yi pu li tong de yan jiu jin zhan
Author(s): 
Pages: 19-22,27
Year: Issue:  1
Journal: WORLD CLINICAL DRUGS

Keyword:  依普利酮高血压心力衰竭药物治疗醛固酮受体阻断剂eplerenone;
Abstract: 依普利酮是第一个获准上市的选择性醛固酮受体阻断剂(SARA),可望用于高血压和心力衰竭等的治疗.本文就依普利酮的临床研究开发进展以及临床实践中所获得的证据进行探讨和总结.
Related Articles
No related articles found